In a research report released Tuesday, Maxim analyst Jason Kolbert maintained a Buy rating on shares of OncoSec Medical Inc (NASDAQ:ONCS) with a $17.00 …
In a research report released Monday, Maxim Group analyst Jason Kolbert maintained a Buy rating on shares of Pluristem Therapeutics Inc. (NASDAQ:PSTI) with an …
Omeros Corporation (NASDAQ:OMER) shot up more than 60% in pre-market trading on Tuesday after the pharmaceutical company announced additional positive data for OMS721 …
Maxim Group analyst Jason Kolbert weighed in today with his views on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), following the news that the company has commenced the promotion …
In a research report issued today, Maxim analyst Jason Kolbert reiterated a Buy rating on StemCells Inc (NASDAQ:STEM) with a $5.00 price target, after …
Bank of America Corp (NYSE:BAC) shares increased 2.74% to $17.
Maxim Group analyst Jason Kolbert came out today with a research report on Gilead Sciences, Inc. (NASDAQ:GILD), reiterating a Buy rating and a price target …
Maxim Group analyst Jason Kolbert was out pounding the table on TrovaGene Inc (NASDAQ:TROV) Thursday, reiterating a Buy rating and price target of $13, …
Maxim Group’s healthcare analyst Jason Kolbert came out with a research report on AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) following the news that the company has reached its …
Maxim Group analyst Jason Kolbert weighed in today with a few insights on Keryx Biopharmaceuticals (NASDAQ:KERX) after the company announced that two national insurance providers have added …